Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.48 USD | +5.10% | +2.32% | -10.37% |
May. 23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
May. 23 | CRISPR Therapeutics Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.15% | 4.56B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+36.87% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Baird Adjusts Price Target on CRISPR Therapeutics to $52 From $46, Keeps Neutral Rating